TR200000602T2 - Yeni karbonik asit türevleri, üretimleri ve kullanımları. - Google Patents
Yeni karbonik asit türevleri, üretimleri ve kullanımları.Info
- Publication number
- TR200000602T2 TR200000602T2 TR2000/00602T TR200000602T TR200000602T2 TR 200000602 T2 TR200000602 T2 TR 200000602T2 TR 2000/00602 T TR2000/00602 T TR 2000/00602T TR 200000602 T TR200000602 T TR 200000602T TR 200000602 T2 TR200000602 T2 TR 200000602T2
- Authority
- TR
- Turkey
- Prior art keywords
- acid derivatives
- carbonic acid
- production
- new carbonic
- new
- Prior art date
Links
- 150000004649 carbonic acid derivatives Chemical class 0.000 title abstract 2
- 229940118365 Endothelin receptor antagonist Drugs 0.000 abstract 1
- 239000002308 endothelin receptor antagonist Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19738578A DE19738578A1 (de) | 1997-09-04 | 1997-09-04 | Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten |
| DE1998111915 DE19811915A1 (de) | 1998-03-18 | 1998-03-18 | Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200000602T2 true TR200000602T2 (tr) | 2000-12-21 |
Family
ID=26039663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/00602T TR200000602T2 (tr) | 1997-09-04 | 1998-08-24 | Yeni karbonik asit türevleri, üretimleri ve kullanımları. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1009741A1 (fr) |
| JP (1) | JP2001514254A (fr) |
| KR (1) | KR20010023615A (fr) |
| CN (1) | CN1269792A (fr) |
| AR (1) | AR017052A1 (fr) |
| AU (1) | AU748610B2 (fr) |
| BG (1) | BG104222A (fr) |
| BR (1) | BR9811631A (fr) |
| CA (1) | CA2302350A1 (fr) |
| CO (1) | CO4970738A1 (fr) |
| HR (1) | HRP980484A2 (fr) |
| HU (1) | HUP0004935A3 (fr) |
| ID (1) | ID25620A (fr) |
| IL (1) | IL134276A0 (fr) |
| NO (1) | NO20001077D0 (fr) |
| NZ (1) | NZ502660A (fr) |
| PL (1) | PL338954A1 (fr) |
| SK (1) | SK1522000A3 (fr) |
| TR (1) | TR200000602T2 (fr) |
| TW (1) | TW546295B (fr) |
| WO (1) | WO1999011629A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19924892A1 (de) * | 1999-06-01 | 2000-12-07 | Basf Ag | Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| AU2007267209A1 (en) * | 2006-05-29 | 2007-12-06 | Nicox S.A. | Nitrated heterocyclic compounds as endothelin receptor antagonist |
| AU2009221179A1 (en) | 2008-03-05 | 2009-09-11 | Boehringer Ingelheim International Gmbh | Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| ES2462065T3 (es) * | 2009-07-10 | 2014-05-22 | Cadila Healthcare Limited | Proceso mejorado para la preparación de Ambrisentán e intermedios novedosos de este |
| AU2011217206A1 (en) | 2010-02-19 | 2012-08-02 | Boehringer Ingelheim International Gmbh | Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| EP2760868B1 (fr) | 2011-08-17 | 2018-04-25 | Boehringer Ingelheim International GmbH | Dérivés de furo[3,4-c]quinoléine, médicaments contenant ces composés, leur utilisation et procédé de leur préparation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4411225A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| WO1997028160A1 (fr) * | 1996-02-01 | 1997-08-07 | Smithkline Beecham Corporation | Antagonistes des recepteurs de l'endotheline |
| DE19614542A1 (de) * | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19636046A1 (de) * | 1996-09-05 | 1998-03-12 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten |
-
1998
- 1998-08-24 CA CA002302350A patent/CA2302350A1/fr not_active Abandoned
- 1998-08-24 KR KR1020007002264A patent/KR20010023615A/ko not_active Withdrawn
- 1998-08-24 EP EP98948859A patent/EP1009741A1/fr not_active Withdrawn
- 1998-08-24 PL PL98338954A patent/PL338954A1/xx unknown
- 1998-08-24 AU AU95333/98A patent/AU748610B2/en not_active Ceased
- 1998-08-24 HU HU0004935A patent/HUP0004935A3/hu unknown
- 1998-08-24 NZ NZ502660A patent/NZ502660A/en unknown
- 1998-08-24 WO PCT/EP1998/005354 patent/WO1999011629A1/fr not_active Ceased
- 1998-08-24 CN CN98808862A patent/CN1269792A/zh active Pending
- 1998-08-24 BR BR9811631-2A patent/BR9811631A/pt not_active IP Right Cessation
- 1998-08-24 IL IL13427698A patent/IL134276A0/xx unknown
- 1998-08-24 SK SK152-2000A patent/SK1522000A3/sk unknown
- 1998-08-24 ID IDW20000386D patent/ID25620A/id unknown
- 1998-08-24 JP JP2000508669A patent/JP2001514254A/ja active Pending
- 1998-08-24 TR TR2000/00602T patent/TR200000602T2/xx unknown
- 1998-09-02 HR HR19811915.1A patent/HRP980484A2/hr not_active Application Discontinuation
- 1998-09-03 CO CO98050561A patent/CO4970738A1/es unknown
- 1998-09-03 TW TW087114595A patent/TW546295B/zh active
- 1998-09-03 AR ARP980104402A patent/AR017052A1/es not_active Application Discontinuation
-
2000
- 2000-03-02 NO NO20001077A patent/NO20001077D0/no not_active Application Discontinuation
- 2000-03-06 BG BG104222A patent/BG104222A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999011629A1 (fr) | 1999-03-11 |
| NO20001077L (no) | 2000-03-02 |
| CA2302350A1 (fr) | 1999-03-11 |
| JP2001514254A (ja) | 2001-09-11 |
| AU748610B2 (en) | 2002-06-06 |
| AR017052A1 (es) | 2001-08-22 |
| HUP0004935A3 (en) | 2001-12-28 |
| NZ502660A (en) | 2002-02-01 |
| CO4970738A1 (es) | 2000-11-07 |
| IL134276A0 (en) | 2001-04-30 |
| CN1269792A (zh) | 2000-10-11 |
| HUP0004935A2 (hu) | 2001-10-28 |
| TW546295B (en) | 2003-08-11 |
| PL338954A1 (en) | 2000-12-04 |
| SK1522000A3 (en) | 2000-08-14 |
| NO20001077D0 (no) | 2000-03-02 |
| HRP980484A2 (en) | 1999-06-30 |
| BG104222A (en) | 2001-02-28 |
| EP1009741A1 (fr) | 2000-06-21 |
| KR20010023615A (ko) | 2001-03-26 |
| ID25620A (id) | 2000-10-19 |
| AU9533398A (en) | 1999-03-22 |
| BR9811631A (pt) | 2000-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199901653T2 (xx) | Fitalazinonlar. | |
| TR200101398T2 (tr) | Pirolidin türevleri-CCR-3 reseptörü antagonistleri. | |
| ZA988158B (en) | Sulfinic acid derivatives and their preparation and use | |
| TR200000197T2 (tr) | Yeni bileşimler | |
| TR199700803T1 (xx) | Trombin-inhibit�rleri olarak yeni dipeptidik amidinler. | |
| BG105205A (en) | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists | |
| TR199901305T2 (xx) | Calpain-�nleyicileri olarak ketonbenzamidler | |
| MXPA02009567A (es) | Benzoilpirzoles y su uso como herbicidas. | |
| TR199901674T2 (fr) | ||
| TR199901282T2 (xx) | Heterosiklik olarak ikame edilmi� yeni benzamitler. | |
| ATE233274T1 (de) | Oxyiminopregnancarbolactone | |
| TR199900856T2 (xx) | Bron�la ilgili terapi maddeleri olarak benzonaftiridinler | |
| SE9702773D0 (sv) | Novel compounds | |
| TR199800623T2 (xx) | Yeni amino asit t�revleri, m�stahzarlar� ve kullan�mlar�. | |
| TR199900486T2 (xx) | Aziniloksi ve fenoksi-diaril-karbonasit t�revleri. | |
| TR199802039T2 (xx) | Yeni alfa-hidroksilik asit t�revleri, �retimleri ve kullan�mlar�. | |
| TR200001182T2 (tr) | Yeni karbonik asit türevleri, üretimleri ve kullanımları. | |
| IL140070A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
| FI973221A0 (fi) | 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina | |
| DE69813565D1 (de) | Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung | |
| TR200000697T2 (tr) | İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| TR199901416T2 (xx) | Heterosiklik karbonikasit t�revleri. | |
| TR199802042T2 (xx) | Yeni karbon asidi t�revleri, �retimleri ve kullan�mlar�. | |
| TR199701202T1 (xx) | Yeni hidroksimik asit t�revleri. |